focus -WSS

focus

author：fashion 2025-10-01 10:39:38 - browse：8

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Retired US general questions alleged Putin, Prigozhin meeting

hotspot

WSS

Readout LOUD: Venture capital, Gilead, and more M&A

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

AI gets buy

N.Y. state detects polio case, first in the U.S. since 2013

Oak trusses raised to roof of fire

entertainment

focus

hotspot

Jerome Adams on the need for new antivirals for Covid

Retired US general questions alleged Putin, Prigozhin meeting

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Hepatitis C has a cure — but many Americans still lack access to it

Why Novartis is going to walk from its acquisition of MorphoSys

Peter Hotez and the public health issue of online harassment

Leqembi, other new Alzheimer’s drugs require better biomarkers

Guidelines to prevent youth baseball injuries need more muscle

Petition to FDA: Get the lead out of consumer hair dyes

focus

Medicare Advantage plans can’t deny care with AI, CMS warns

A new study sees potential in DNA sequencing of infants

Palantir health business leans on meeting customers’ needs

340B reform proposal comes out of Senate working group

A single Democrat is willing to weaken Medicare negotiation power

Devoted Health’s losses in Medicare Advantage persist

leisure time

knowledge

hotspot

knowledge